ARCHIVES

Platinum-Free Break Enhances Therapy After First Relapse In Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 26 No. 3 | March 28, 2003

Download PDF Visit The Full Archive

Related Articles

FDA Begins To Examine Its Role In Allowing Misleading Consumer Advertising.

May 18, 2007

Litton’s Government Contracts Status Under Review

September 6, 1985

Editorial: Rumor Mill Fills The Gap When Access Denied

December 16, 1994

NCI Will Encourage More Activity In Environment Carcinogenesis

June 21, 1974

When Screening Mammography Meets Health Care Reform, Opinions Proliferate

February 4, 1994

In Brief: Cancer Act renewal, Appropriations Bill Caught In Squeeze Between Conventions

August 1, 1980